Alan CochraneProfile page
Professor
Temerty Faculty of Medicine, Department of Molecular Genetics
Orcid identifier0000-0002-8924-5682
- ProfessorTemerty Faculty of Medicine, Department of Molecular Genetics
- 416-978-2500 (Work)
- (416) 978-4550 (Work)
- University of Toronto, Molecular Genetics, 1 King's College Circle msb 7368, Toronto, Ontario, m5s1a8, Canada
BIO
Dr. Alan Cochrane is a Professor with the Department of Molecular Genetics at the Temerty Faculty of Medicine. Dr. Cochrane is actively affiliated with the School of Graduate Studies-Department of Molecular Genetics.
Alan Cochrane completed his PhD in 1988 from Queen’s University University and postdoctoral studies from Roche Institute of Molecular Biology. He is a professor at the University of Toronto.. He has published more than 70 papers and serving on the editorial board of Retrovirology. Over the last several years, his reserach has been focused on the regulation of viral RNA processing, with particular focus on the identification of small molecule modulators of RNA splicing and their utility in the suppression of HIV-1 and adenovirus replication
Alan Cochrane completed his PhD in 1988 from Queen’s University University and postdoctoral studies from Roche Institute of Molecular Biology. He is a professor at the University of Toronto.. He has published more than 70 papers and serving on the editorial board of Retrovirology. Over the last several years, his reserach has been focused on the regulation of viral RNA processing, with particular focus on the identification of small molecule modulators of RNA splicing and their utility in the suppression of HIV-1 and adenovirus replication
MEDIA
Showing media thumbnail 1 out of 1.
ACADEMIC POSITIONS
- ProfessorUniversity of Toronto, Molecular Genetics, Toronto, Canada1 Jul 1994 - present
DEGREES
- Ph.D.Queen's University, Kingston, Canada1987
LANGUAGES
- EnglishCan read, write, speak, understand and peer review
- FrenchCan read, speak and understand
AVAILABILITY
- Media enquiries
INSTITUTIONAL STRATEGIC INITIATIVES
- PRiME (Precision Medicine Initiative)
- EPIC (Emerging Pathogens and Infectious Diseases Consortium)